SZKB Ethikfonds Wachstum IA

Reference Data

ISIN CH1128291270
Valor Number 112829127
Bloomberg Global ID
Fund Name SZKB Ethikfonds Wachstum IA
Fund Provider Schwyzer Kantonalbank 6431 Schwyz, Schweiz
Phone: +41 58 800 20 20
E-Mail: fonds@szkb.ch
Web: www.szkb.ch
Fund Provider Schwyzer Kantonalbank
Representative in Switzerland
Distributor(s)
Asset Class Equities
EFC Category
Distribution Policy Distribution
Home Country Switzerland
Issuing Condition The fund does not charge any issuing commission and/or fees (units are issued at the NAV)
Redemption Condition The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV)
Investment Strategy *** This fund is actively managed. The investment objective is to preserve capital and to grow it over the long term through direct investments in equities and bonds. We work with the estab-lished external partner "ISS ESG", which defines the sustainable equity universe. The invest-ment universe is defined on the basis of social and environmental sustainability criteria as well as governance aspects. In doing so, we pursue a combination of an absolute best-in-class approach and explicit standard- and sector-based exclusions. In a second step, a fundamental analysis is carried out by our specialists. In addition, climate risks are considered throughout the investment process to ensure compatibility with the Paris Climate Agreement at fund level.
Peculiarities

Fund Prices

Current Price * 1,026.91 CHF 31.03.2025
Previous Price * 1,030.19 CHF 28.03.2025
52 Week High * 1,095.98 CHF 13.02.2025
52 Week Low * 998.60 CHF 10.09.2024
NAV * 1,026.91 CHF 31.03.2025
Issue Price *
Redemption Price *
Closing Price *
Indicative Minimum Price
Fund Assets *** 37,301,501
Unit/Share Assets *** 6,864,635
Trading Information SIX

Performance

YTD Performance -0.91% 30.12.2024
31.03.2025
1 month -4.48% 28.02.2025
31.03.2025
3 months -1.36% 03.01.2025
31.03.2025
6 months -0.36% 30.09.2024
31.03.2025
1 year +2.84% 10.09.2024
31.03.2025
2 years +2.84% 10.09.2024
31.03.2025
3 years +2.69% 12.04.2022
31.03.2025
5 years - -

Tax Data

Equity Participation Rate in %
Share of Total Fund Assets in %
Real Estate Rate in %
ADDI
ADDI Date

Top 10 Holdings ***

SZKB Ethikfonds Kapitalgewinn D 29.00%
Eli Lilly and Co 1.19%
Abbott Laboratories 1.14%
Jabil Inc 1.14%
Keysight Technologies Inc 1.12%
Best Buy Co Inc 1.11%
Edwards Lifesciences Corp 1.10%
Procter & Gamble Co 1.07%
Intuitive Surgical Inc 1.06%
AbbVie Inc 1.06%
Last data update 31.01.2025

Cost / Risk

TER 0.89%
TER date 30.09.2024
Performance Fee ***
PTR
Max. Management Fee *** 1.50%
Ongoing Charges *** 0.89%
SRRI ***
SRRI date *** 28.02.2025

Breakdowns

Countries ***

Stock Sectors ***

Bond Sectors ***


* NAV / Issue Price exclusive commissions, for listed funds NAV or closing price
** Calculation of interim profit followed § 9 Satz 2 InvStG
*** Data source: Morningstar (Data is based on the rescaled long position of the holdings)